Treace Medical Concepts, Inc.
TMCI
$4.06
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.81% | -1,775.05% | -6.04% | 17.96% | 14.75% |
| Total Depreciation and Amortization | -63.47% | 46.16% | 28.79% | 21.74% | 28.92% |
| Total Amortization of Deferred Charges | 254.05% | -0.56% | 1.35% | 0.00% | -1.33% |
| Total Other Non-Cash Items | -5.79% | 5.52% | 23.66% | 12.21% | 24.85% |
| Change in Net Operating Assets | 91.21% | 22.94% | 22.20% | 137.46% | 394.80% |
| Cash from Operations | 72.46% | -90.78% | 23.22% | 78.05% | 158.14% |
| Capital Expenditure | 13.58% | 21.99% | 1.89% | -175.71% | 9.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -388.30% | 85.74% | 33.84% | -93.75% | -78.54% |
| Cash from Investing | -312.67% | 182.55% | 51.59% | -114.52% | -150.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -23.53% | 22.81% | 2,912.50% | -62.70% | 128.85% |
| Repurchase of Common Stock | 48.38% | -141.94% | -- | -- | -69.20% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -108.51% | 5,215.38% | -225.00% | 217.36% | -52.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.57% | 497.63% | 93.97% | -160.13% | 155.43% |